Sujeong Han

Sujeong Han

Auto-generated profile, based on publicly available information

Sujeong Han

Department of Artificial Intelligence, Chung-Ang University, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2026 in Blood Advances
Verified
Journal Article
Open access
SYSang Eun Yoon
Sang Eun Yoon
WKWoorim Kang
Woorim Kang
JCJunhun Cho
Junhun Cho
HCHyeon Ji Cho
Hyeon Ji Cho
MCMauricio Chalita
Mauricio Chalita
SKSeok Jin Kim
Seok Jin Kim
CD19 chimeric antigen receptor (CAR) T-cell therapy has revolutionized treatment for relapsed/refractory diffuse large B-cell lymphoma (R/R-DLBCL), but challenges such as posttreatment failure and immune-related adverse events (AEs) persist. This study explores the gut microbiome as a predictive biomarker for CAR T-cell therapy outcomes and toxicity. Stool and serum samples from patients with R/R-DLBCL were analyzed at apheresis (47 samples) and 1 month after infusion (32 samples) using whole-genome sequencing metagenomics. When compared with healthy controls and newly-diagnosed DLBCL, R/R-DLBCL showed significant gut dysbiosis, characterized by increased Proteobacteria and Enterobacteriaceae. Responders had higher levels of Bacteroides fragilis, whereas nonresponders exhibited higher levels of Faecalibacterium prausnitzii. Functional metagenomic analysis suggested enrichment of inosine biosynthesis pathways in responders, and elevated serum inosine demonstrated an exploratory association with improved progression-free survival. Distinct microbial taxa and serum fatty acid profiles were also linked to CAR T-cell–related AEs, with higher acetate and butyrate levels in patients without AEs and increased isovalerate in those with AEs. These findings indicate that gut microbiome features—particularly Bacteroides fragilis and inosine metabolism—may serve as candidate biomarkers for CAR T-cell therapy outcomes and toxicity. However, given the exploratory nature of these analyses and the limited cohort size, results should be interpreted cautiously. Larger, prospective studies will be required to validate these observations and to assess the potential of microbiome-based strategies to optimize CAR T-cell therapy in R/R-DLBCL.

23 July 2025 in Expert Systems with Applications
Verified
Journal Article
Closed access
SHSujeong Han
Sujeong Han
HMHyeonji Moon
Hyeonji Moon
SLSanghyuck Lee
Sanghyuck Lee
AMA-Seong Moon
A-Seong Moon
MSMin-Kyung Sung
Min-Kyung Sung
Jaesung LeeJaesung Lee
Jaesung Lee

26 August 2026 in Journal of Plant Research
Verified
Journal Article
Open access
PDF file
ATAtsuko Takano
Atsuko Takano
HMHyeonji Moon
Hyeonji Moon
MSMasato Shirai
Masato Shirai
STShuichiro Tagane
Shuichiro Tagane
DVDiego Tavares Vasques
Diego Tavares Vasques
SKSangtae Kim
Sangtae Kim
Herbarium specimens are physical, verifiable records that form the basis of taxonomic knowledge and biodiversity research. Their large-scale digitization has produced extensive collections of high-resolution images and associated specimen metadata, creating conditions in which artificial intelligence (AI) can play an important role in plant taxonomy, collection management, and ecological research. Early AI applications have primarily focused on automated species identification based on individual specimen images. Although increasingly accurate, such approaches remain limited by their emphasis on single-specimen label prediction and by treating identification outputs as final analytical decisions. Recent methodological advances—including segmentation-based preprocessing, automated trait extraction, structured extraction of label data, detection of potentially misidentified specimens, and multimodal integration of visual, textual, and genetic information—extend AI applications beyond species identification toward broader analytical frameworks, encompassing taxonomic interpretation as well as ecological and biodiversity research. In these approaches, specimens are placed within a shared analytical space, and identification results are used to support comparisons across multiple specimens rather than being treated as final decisions for single individuals. This multi-specimen perspective enables quantitative examination of species boundaries, morphological variation, data inconsistencies, and taxonomic stability within curated collections. In this context, AI serves not as an ultimate decision-maker but as a decision-support tool embedded in expert-guided workflows and biodiversity knowledge infrastructures. These developments can be summarized as Integrative Taxonomic AI , an approach that employs learned morphospaces to interpret and refine taxonomic categories by integrating multimodal evidence and curated specimen data under expert guidance.